Other potential markers include IKZF1, BCAT1, NTRK3, SRFP1-2, EHD3, TMEM240, SMAD3, and VIM, though further validation is necessary to confirm clinical utility and integration into routine CRC screening workflows [142,143]. This evidence concerns the gene VIM and colorectal carcinoma.